Working… Menu
Trial record 11 of 24 for:    inno-206

Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02200757
Recruitment Status : Unknown
Verified January 2016 by CytRx.
Recruitment status was:  Recruiting
First Posted : July 25, 2014
Last Update Posted : August 18, 2016
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : September 2016
Estimated Study Completion Date : July 2017